7774 — Japan Tissue Engineering Co Cashflow Statement
0.000.00%
- ¥27bn
- ¥23bn
- ¥3bn
Annual cashflow statement for Japan Tissue Engineering Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -230 | -463 | -494 | -725 | 147 |
Depreciation | |||||
Non-Cash Items | 6.79 | 1.8 | -10.9 | -0.42 | 30 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 14.3 | -66.8 | 155 | -28.2 | -36.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -84.6 | -400 | -225 | -623 | 274 |
Capital Expenditures | -91.2 | -74.4 | -117 | -176 | -273 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 300 | 200 | 0.751 | 1,301 | 31 |
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 209 | 126 | -116 | 1,125 | -242 |
Financing Cash Flow Items | — | — | — | — | -0.001 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -3.19 | -1.3 | -0.823 | -0.803 | -0.134 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 121 | -275 | -343 | 501 | 31.8 |